A Precision Medicine Approach to Optimize Modulator Therapy for Rare CFTR Folding Mutants
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Precision Medicine Approach to Optimize Modulator Therapy for Rare CFTR Folding Mutants
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 7, Pages 643
Publisher
MDPI AG
Online
2021-07-08
DOI
10.3390/jpm11070643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modulators of CFTR. Updates on clinical development and future directions
- (2021) Emmanuelle Bardin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rescue of multiple class II CFTR mutations by elexacaftor+ tezacaftor+ivacaftor mediated in part by the dual activities of Elexacaftor as both corrector and potentiator
- (2021) Onofrio Laselva et al. EUROPEAN RESPIRATORY JOURNAL
- CFTR Function and Clinical Response to Modulators Parallel Nasal Epithelial Organoid Swelling
- (2021) Justin D Anderson et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Discovery of CFTR modulators for the treatment of cystic fibrosis
- (2021) Miquéias Lopes-Pacheco et al. Expert Opinion on Drug Discovery
- Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
- (2021) Valeria Capurro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR
- (2021) Guido Veit et al. Journal of Cystic Fibrosis
- Personalized Medicine Based on Nasal Epithelial Cells: Comparative Studies with Rectal Biopsies and Intestinal Organoids
- (2021) Iris A. L. Silva et al. Journal of Personalized Medicine
- Co-Translational Folding of the First Transmembrane Domain of ABC-Transporter CFTR is Supported by Assembly with the First Cytosolic Domain
- (2021) Bertrand Kleizen et al. JOURNAL OF MOLECULAR BIOLOGY
- CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
- (2020) Miquéias Lopes-Pacheco Frontiers in Pharmacology
- Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants
- (2020) Onofrio Laselva et al. Journal of Cystic Fibrosis
- CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation
- (2020) Puay-Wah Phuan et al. Journal of Cystic Fibrosis
- Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
- (2020) Guido Veit et al. JCI Insight
- CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials
- (2019) Scott C. Bell et al. Journal of Cystic Fibrosis
- Mutation-specific dual potentiators maximize rescue of CFTR gating mutants
- (2019) Guido Veit et al. Journal of Cystic Fibrosis
- Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations
- (2019) Karin M. de Winter – de Groot et al. Journal of Cystic Fibrosis
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
- (2019) Peter G. Middleton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of ivacaftor in cystic fibrosis patients with non- G551D gating mutations
- (2018) Jennifer Guimbellot et al. Journal of Cystic Fibrosis
- EPS3.06 Safety, pharmacokinetics and pharmacodynamics of the CFTR corrector FDL169
- (2018) A. Horsley et al. Journal of Cystic Fibrosis
- Correctors of the Major Cystic Fibrosis Mutant Interact through Membrane-Spanning Domains
- (2018) Onofrio Laselva et al. MOLECULAR PHARMACOLOGY
- Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site
- (2018) Steven V. Molinski et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Structure-guided combination therapy to potently improve the function of mutant CFTRs
- (2018) Guido Veit et al. NATURE MEDICINE
- Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?
- (2018) Iwona Pranke et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mutation-specific downregulation of CFTR2 variants by gating potentiators
- (2017) Radu G Avramescu et al. HUMAN MOLECULAR GENETICS
- Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L
- (2017) Isobel E.R. MacKenzie et al. Journal of Cystic Fibrosis
- Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
- (2017) Steven M. Rowe et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies
- (2017) Meghan E. McGarry et al. PEDIATRIC PULMONOLOGY
- Ivacaftor for the p.Ser549Arg (S549R) gating mutation – The Israeli experience
- (2017) Adi Dagan et al. RESPIRATORY MEDICINE
- Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
- (2017) Iwona M. Pranke et al. Scientific Reports
- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
- (2013) Carlos M. Farinha et al. CHEMISTRY & BIOLOGY
- VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
- (2013) Hong Yu Ren et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
- (2012) Juan L. Mendoza et al. CELL
- Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
- (2012) Wael M. Rabeh et al. CELL
- Ivacaftor potentiation of multiple CFTR channels with gating mutations
- (2012) Haihui Yu et al. Journal of Cystic Fibrosis
- Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia
- (2012) Guido Veit et al. MOLECULAR BIOLOGY OF THE CELL
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CFTR: folding, misfolding and correcting the ΔF508 conformational defect
- (2011) Gergely L. Lukacs et al. TRENDS IN MOLECULAR MEDICINE
- Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
- (2010) T. Okiyoneda et al. SCIENCE
- Cooperative Assembly and Misfolding of CFTR Domains In Vivo
- (2009) Kai Du et al. MOLECULAR BIOLOGY OF THE CELL
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CFTR Function and Prospects for Therapy
- (2008) John R. Riordan Annual Review of Biochemistry
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search